Company Filing History:
Years Active: 2002
Title: Efraim Lavie: Innovator in Radiotherapeutic Sources
Introduction
Efraim Lavie is a notable inventor based in Mazkeret-Batia, Israel. He has made significant contributions to the field of radiotherapy through his innovative patent. His work focuses on the development of a radiotherapeutic source that utilizes Rhenium, which is generated in situ from Tungsten.
Latest Patents
Efraim Lavie's most recent patent is titled "In-situ-generated solid radiation source based on Tungsten 188 /Rhenium 188 and use thereof." This invention describes a therapeutic device that employs a radioactive source for the in situ generation of Rhenium from Tungsten. The patent highlights the use of metallic Tungsten or a metal oxide of Tungsten as a key component in the therapeutic source.
Career Highlights
Efraim Lavie is affiliated with the State of Israel Atomic Energy Commission, where he has been instrumental in advancing research in radiotherapy. His work has the potential to improve treatment options for patients requiring radiation therapy.
Collaborations
Efraim has collaborated with notable colleagues, including Daniel Kijel and Eliahu Sayag, who have contributed to his research endeavors.
Conclusion
Efraim Lavie's innovative work in the field of radiotherapy exemplifies the importance of advancements in medical technology. His patent on the in-situ generation of Rhenium from Tungsten represents a significant step forward in therapeutic applications.